Biotech and Pharmaceutical Stocks, Recent Clinical Trial Results
- Unvaccinated Are Nearly 6x More Likely to End Up in the Hospital, According to Analysis of New Jersey's COVID Cases
- Travere Therapeutics Announces Successful Outcome from Type A Meeting with U.S. FDA for Sparsentan in Focal Segmental Glomerulosclerosis
- Valbiotis Announces the Completion of Recruitment for the Phase II HEART Clinical Study Conducted With TOTUM•070 in Hypercholesterolemia
- New Tezepelumab Data Show 86% Reduction In Exacerbations In Patients With Severe Asthma And Comorbid Nasal Polyps
- Famotidine Celebrex combination Does Not Reduce Time to Recovery or Mortality in Critically Ill Patients in the I-SPY COVID Trial
- COVID-19 Vaccine Clinical Trial in People With Autoimmune Disease Starts at Feinstein Institutes
- Pfizer Announces Start of Phase 3 Clinical Trial in Adults for Its Investigational Vaccine Against Respiratory Syncytial Virus (RSV)
- Astellas Provides Update on ASPIRO Clinical Trial of AT132 in Patients with X-linked Myotubular Myopathy
- Data from NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients Published in Clinical Infectious Diseases
- Merck and Ridgeback Biotherapeutics Announce Initiation of Pivotal Phase 3 MOVe-AHEAD Study Evaluating Molnupiravir for Post-Exposure Prophylaxis of COVID-19 Infection
- Moderna Announces Submission of Initial Data to U.S. FDA for Its COVID-19 Vaccine Booster
- New Affron saffron study shows a quick effect on sleep at low dosage
- Clinical Trial Provides Preliminary Evidence of a Cure for Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) and Long Covid
- SK Bioscience and GSK Start Phase 3 trial of Adjuvanted COVID-19 Vaccine Candidate
- Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia